OyaGen Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $286K

  • Investors
  • 1

OyaGen General Information

Description

Operator of a biotechnology company intended to develop novel pharmaceutical therapies to exploit ribonucleic acid editing and deoxyribonucleic acid editing enzymes. The company's therapies harness the editing process of the enzymes that chemically alter RNA or DNA molecules and change the genetic code, enabling physicians to treat human immunodeficiency virus in an enhanced way.

Contact Information

Website
www.oyageninc.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1200 Jefferson Road
  • Suite 206
  • Rochester, NY 14623
  • United States
+1 (585)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 1200 Jefferson Road
  • Suite 206
  • Rochester, NY 14623
  • United States
+1 (585)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OyaGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Grant 01-Jul-2020 $286K Completed Generating Revenue
9. Later Stage VC 11-Jun-2019 Completed Generating Revenue
8. Grant 06-Aug-2018 Completed Generating Revenue
7. Grant 15-Apr-2015 Completed Generating Revenue
6. Later Stage VC 16-Sep-2013 Completed Generating Revenue
5. Later Stage VC (Series B) 11-Oct-2012 Completed Generating Revenue
4. Later Stage VC (Series A) 17-Sep-2009 Completed Generating Revenue
3. Early Stage VC 02-Aug-2006 Completed Startup
2. Early Stage VC 05-Sep-2005 $12M $12M Completed Startup
1. Grant 21-Apr-2004 $2.5K Completed Startup
To view OyaGen’s complete valuation and funding history, request access »

OyaGen Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view OyaGen’s complete cap table history, request access »

OyaGen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to develop novel pharmaceutical therapies to exploit ribonucleic acid editi
Drug Discovery
Rochester, NY
5 As of 2026

New Haven, CT
 

Plymouth Meeting, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OyaGen Competitors (23)

One of OyaGen’s 23 competitors is Alphina Therapeutics, a Venture Capital-Backed company based in New Haven, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alphina Therapeutics Venture Capital-Backed New Haven, CT
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Cognition Therapeutics Formerly VC-backed New York, NY
Ayala Pharmaceuticals Corporation Wilmington, DE
VLPbio Formerly VC-backed Boecillo, Spain
You’re viewing 5 of 23 competitors. Get the full list »

OyaGen Patents

  • 58

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

OyaGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230285434-A1 Method for treating arenaviridae infections Inactive 14-Apr-2020
WO-2021211757-A1 Method for treating arenaviridae infections Inactive 14-Apr-2020
US-20230233591-A1 Method for treating poxviridae infections Inactive 14-Apr-2020
WO-2021211759-A1 Method for treating poxviridae infections Inactive 14-Apr-2020
AU-2021217130-A1 Method for treating coronavirus infections Inactive 04-Feb-2020 A61K31/519
To view OyaGen’s complete patent history, request access »

OyaGen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OyaGen Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
To view OyaGen’s complete investors history, request access »

Ready to get started?

Request a free trial

OyaGen FAQs

  • When was OyaGen founded?

    OyaGen was founded in 2003.

  • Where is OyaGen headquartered?

    OyaGen is headquartered in Rochester, NY.

  • What is the size of OyaGen?

    OyaGen has 5 total employees.

  • What industry is OyaGen in?

    OyaGen’s primary industry is Drug Discovery.

  • Is OyaGen a private or public company?

    OyaGen is a Private company.

  • What is OyaGen’s current revenue?

    The current revenue for OyaGen is .

  • How much funding has OyaGen raised over time?

    OyaGen has raised $15.6M.

  • Who are OyaGen’s investors?

    National Institutes of Health has invested in OyaGen.

  • Who are OyaGen’s competitors?

    Alphina Therapeutics, Inovio Pharmaceuticals, Cognition Therapeutics, Ayala Pharmaceuticals, and VLPbio are some of the 23 competitors of OyaGen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process